IBD and UC

Inflammatory Bowel Disease (IBD)

  • Introduction to IBD
    • Discussion of small and large intestine disorders.
    • Focus on inflammatory bowel disease (IBD).
    • Caution against confusion with irritable bowel syndrome (IBS).

Types of IBD

  • Two primary forms of IBD:
    • Crohn's Disease
    • Ulcerative Colitis (UC)

Common Characteristics of IBD

  • Both types involve inflammation of intestinal mucosa.
  • Shared symptoms include:
    • Abdominal pain
    • Diarrhea
    • Fever
    • Food intolerances
    • Weight loss
    • Possible anemias
  • Disease pattern includes periods of remission and flare-ups.
  • Diagnosis of exact cause remains unclear, but theories include:
    • Genetic factors
    • Inappropriate immune response (possibly autoimmune) triggered by environmental factors (unidentified).
    • Food intolerances intermittently considered but no specific problematic foods identified so far.
  • Demographics:
    • Most common in teens through early 30s.
    • Affects men and women equally.
    • More prevalent in Caucasians.

Distinction between Crohn's Disease and Ulcerative Colitis

  • Key differences between the two forms of IBD:
    • Crohn's disease can affect any part of the gastrointestinal (GI) tract; UC is limited to the large intestine and rectum.
    • Crohn's presents with inflamed segments separated by healthy segments (skip lesions); UC has continuous inflammation.

Specific Features of Crohn's Disease

  • Localization: Affects any part of the GI tract; commonly affects:
    • Terminal ileum
    • Colon
  • Characteristics:
    • Transmural inflammation: affects multiple layers (mucosal through submucosal).
    • Cobblestone appearance of ulcerations; presence of granulomas (clusters of inflamed immune cells).
    • Notable absence of these features in UC.

Symptoms and Complications of Crohn's Disease

  • Common Symptoms:
    • Inflammation, ulcerations, severe abdominal pain, diarrhea.
  • Complications:
    • Strictures or obstructions due to scar tissue from recurrent inflammation.
    • Malabsorption leading to anemia (from both malabsorption and blood loss from ulcers).
    • Formation of fistulas—abnormal tunnels through all layers of the GI tract, often seen in perianal areas.
    • Extraintestinal symptoms:
    • Inflammation in joints, skin rashes and sores, eye inflammation.
    • Unclear relation to the autoimmune response affecting non-GI areas.

Ulcerative Colitis (UC)

  • Localization: Generally restricted to the large intestine, starting in the rectum or sigmoid colon.
  • Inflammation Characteristics: Continuous without skipping segments; primarily affects mucosal and submucosal layers only.
  • Fistula Formation: Rarely seen in UC compared to Crohn's.
  • Common symptoms:
    • Bloody diarrhea
    • Abdominal pain
    • Anorexia and weight loss
    • Possible anemia due to blood loss.

Complications of UC

  • Major fluid and electrolyte loss (as absorption occurs in the large bowel).
  • Malnutrition potential; usually less severe than in Crohn's.
  • Lower risk of fistulas and strictures in UC.
  • Increased colorectal cancer risk compared to the general population.
  • Primary Sclerosing Cholangitis: Rare liver disease associated with UC, where about 50% of affected individuals also have UC.

Toxic Megacolon

  • Serious rare complication of UC leading to immobilization and possible rupture of the inflamed colon—a medical emergency requiring colectomy.

Treatment and Management of IBD

  • No cure for IBD; various medication treatments for acute flare-ups include:
    • Anti-inflammatory drugs
    • Corticosteroids
    • Immunosuppressive drugs
    • Biologics like Remicade and Humira
    • Methotrexate: Monitor for potential folate deficiency.
  • Importance of monitoring lab values including hemoglobin, hematocrit, serum ferritin for anemia.
  • Patients on immunosuppressive drugs have increased infection risk, emphasizing food safety.
  • Dietary management is crucial:
    • Detailed dietary history to identify and eliminate potential food triggers during flare-ups (no universal trigger foods).
    • Recommended dietary practices during flare-ups:
    • Low-residue diet
    • Avoidance of lactose, high-fructose, and greasy foods (due to common fat malabsorption).
    • Consideration of parenteral nutrition if needed.

Nutritional Needs During IBD

  • Higher protein intake may be warranted (1-1.5 g/kg) due to inflammation and healing needs, especially with corticosteroids.
  • Fat malabsorption indicated by steatorrhea (oily, foul-smelling stools); suggest low-fat diets or medium-chain triglycerides (MCTs) for easier digestion.
  • Concerns for micromineral deficiencies from bowel resections (e.g., B12 deficiency if a portion of the ileum is removed).

Probiotics and Other Dietary Considerations

  • Probiotic use during flare-ups is controversial; potential risks include infections.
  • Some evidence supports probiotics for maintaining remission.
  • Omega-3 fatty acids may reduce acute inflammation; Mediterranean diet shows potential benefits for remission due to anti-inflammatory properties.

Support and Resources

  • Social support groups can be beneficial for individuals with IBD.
  • Reference to the Crohn's and Colitis Foundation of America for further information and resources.

Sample Clinical Statement

  • A sample recommendation statement for managing flare-ups in IBD patients is provided.